Click on a filter below to refine your search. Remove a filter to broaden your search.
New research explores whether what causes cancer in some people may protect them from developing Alzheimer’s disease.
The FDA received licensing applications sooner and had shorter review times compared with the European Medicines Agency.
AI assisted pancreatic and breast cancer detection were the focus of separate studies published this week in Nature Medicine.
Researchers devised a new way to ensure that older adults aren’t being overtreated or tested needlessly via unnecessary screenings.
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.
Patients and caregivers scored higher on AML knowledge and perceived greater efficacy in communicating with oncologists.
Immunocompromised patients still can receive convalescent plasma.
An estimated 31% of breast cancers were overdiagnosed among screened women aged 70 to 74 years.
These preexisting conditions affect functional impairment, mobility and falls.
Recent research has helped raise awareness about the potential dangers of using chemical hair relaxers.